SOPHiA GENETICS to Present at the J.P. Morgan 2024 Healthcare Conference
14 Dezember 2023 - 6:43PM
SOPHiA GENETICS (NASDAQ: SOPH) today announced that Jurgi Camblong,
PhD., Chief Executive Officer and Co-founder, is scheduled to
present at the J.P. Morgan 2024 Healthcare Conference
on Thursday, January 11, 2024, at 9:00 a.m.
PST in San Francisco.
Live, listen-only webcasts of this presentation can be accessed
by visiting the Investors section of the SOPHiA
GENETICS website at ir.sophiagenetics.com. A replay of
the webcast will be available shortly after the conclusion of the
presentation and archived on the company's website for two weeks
following the presentation.
About SOPHiA GENETICSSOPHiA GENETICS
(Nasdaq: SOPH) is a software company dedicated to establishing the
practice of data-driven medicine as the standard of care and for
life sciences research. It is the creator of the SOPHiA DDM™
Platform, a cloud-native platform capable of analyzing data and
generating insights from complex multimodal data sets and different
diagnostic modalities. The SOPHiA DDM™ Platform and related
solutions, products and services are currently used by a broad
network of hospital, laboratory, and biopharma institutions
globally. For more information, visit SOPHiAGENETICS.COM, or
connect on X, LinkedIn, Facebook,
and Instagram. Where others see data, we see
answers.
Investor Contact:Kellen Sangerir@sophiagenetics.com
Media Contact:Kelly Katapodismedia@sophiagenetics.com
Sophia Genetics (NASDAQ:SOPH)
Historical Stock Chart
Von Apr 2024 bis Mai 2024
Sophia Genetics (NASDAQ:SOPH)
Historical Stock Chart
Von Mai 2023 bis Mai 2024